The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Sarepta Therapeutics Inc’s current trading price is -92.07% away from its 52-week high, while its distance from the 52-week low is 14.55%. The stock’s price range for this period has been between $10.41 and $150.48 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 13.73 million for the day, a number notably higher than the average daily volume of 8.61 million over the last three months.
The stock price for Sarepta Therapeutics Inc (SRPT) currently stands at $11.93. The stock experienced a substantial increase in the last session, hitting $80.0 after starting at $11.93. The stock’s lowest price was $0.0 before closing at $12.88.
Sarepta Therapeutics Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $150.48 on 07/29/24 and a low of $10.41 for the same time frame on 07/24/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Sarepta Therapeutics Inc (SRPT) has experienced a quarterly decline of -80.68% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.17B and boasts a workforce of 1372 employees.
Sarepta Therapeutics Inc: What Analysts Are Saying
As of right now, 3 analysts are rating Sarepta Therapeutics Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 17 analysts are recommending to HOLD this stock, 3 of them gave the stock UNDERWEIGHT rating, and 2 analysts are rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 46.95, with a change in price of -89.29. Similarly, Sarepta Therapeutics Inc recorded 6,467,335 in trading volume during the last 100 days, posting a change of -88.21%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for SRPT stands at 1.18. Similarly, the long-term debt-to-equity ratio is also 1.18.
SRPT Stock Stochastic Average
Sarepta Therapeutics Inc’s raw stochastic average for the past 50 days is presently 4.49%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 12.17%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 14.05% and 12.80%, respectively.
SRPT Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. This year’s metric has recorded a Price decrease of -91.92%. However, over the past six months, we’ve seen a stronger performance of -89.99%. The price of SRPT leaped by -31.67% over the last 30 days. And in the last five days, it has fallen by -15.24%.
